Merck KGaA (MKGAF.PK) Doesn't Rule Out Pursuing Lung-Cancer Vaccine
5/17/2013 9:29:12 AM
More...
|
Merck KGaA (MKGAF.PK) Ups Commitment to MS Ventures to $129 Million
5/17/2013 7:57:31 AM
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium
5/9/2013 6:40:28 AM
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium
4/30/2013 12:21:46 PM
More...
|
Cetrotide Manufacturing Rights Transferred to Merck KGaA (MKGAF.PK)
4/17/2013 8:03:31 AM
More...
|
Merck KGaA (MKGAF.PK) Closes $2.6 Billion Refinancing
3/27/2013 7:14:06 AM
More...
|
Merck KGaA (MKGAF.PK) Drug Fails in Late-Stage Brain Cancer Trial
2/25/2013 8:33:54 AM
More...
|
Merck KGaA (MKGAF.PK), Oncothyreon Inc. (ONTY) Hit as Cancer Vaccine Fails
12/19/2012 7:06:37 AM
More...
|
Merck KGaA (MKGAF.PK) Eyes Expansion in Indonesia
12/3/2012 8:21:49 AM
More...
|
Merck KGaA (MKGAF.PK) Will Not Sell OTC Unit
11/27/2012 7:42:26 AM
More...
|
|